• NET Formation in CML and Differential TKI Effects

  2026-08-19

  The reference study shows that neutrophil extracellular trap formation is already elevated in treatment-naïve chronic myeloid leukemia and is differentially modified by tyrosine kinase inhibitors. Its combination of patient-derived neutrophils with a BCR-ABL1-engineered differentiation model identifies PAD4-linked NET biology as a potential mechanistic bridge between CML and treatment-associated vascular risk.

• Ibrutinib, CSK Inhibition, and Atrial Fibrillation

  2026-08-19

  This study identifies inhibition of C-terminal Src kinase, rather than Bruton tyrosine kinase blockade itself, as the principal mechanism linking ibrutinib to atrial fibrillation. By combining mouse electrophysiology, cardiac genetics, chemoproteomics, and pharmacovigilance analysis, the authors connect CSK loss with atrial remodeling, fibrosis, and inflammation. The findings illustrate why off-target kinase activity can shape both therapeutic safety and experimental interpretation.

• WY-14643 (Pirinixic Acid) in PPARα Research

  2026-08-18

  WY-14643 (Pirinixic Acid) gives researchers a practical PPARα activation tool for connecting lipid metabolism regulation with inflammatory and cell-death readouts. This workflow-focused guide shows how to use it in metabolic disorder research, endothelial inflammation assays, and mechanistic liver-injury studies while avoiding solubility and interpretation errors.

• Camptothecin and the Evolutionary Logic of DNA Damage

  2026-08-18

  Camptothecin is more than a benchmark topoisomerase I inhibitor: it is a controlled way to study how defined DNA lesions connect acute cell fate with longer-term genome adaptation. This thought-leadership perspective integrates its DNA damage and autophagy biology with a 2026 Cell study showing that prion-like protein self-assembly can tune mutagenesis, while distinguishing established evidence from translational hypotheses.

• BIBR 1532: Separating Telomerase and Telomere Stress

  2026-08-17

  BIBR 1532 is a selective telomerase inhibitor for distinguishing direct hTERT suppression from delayed telomere attrition and DNA-damage phenotypes. This article develops a two-clock assay strategy grounded in recent CF10–EdU findings and leukemia apoptosis data.

• CBD, FAAH, and Orofacial Inflammatory Pain

  2026-08-17

  This 2026 study shows that cannabidiol (CBD) can reduce both nociceptive and affective consequences of inflammatory pain through coordinated peripheral and central mechanisms involving FAAH, cannabinoid receptors, inflammatory mediators, and serotonin dynamics. Its multilevel design provides a useful framework for studying endocannabinoid signaling modulation while distinguishing sensory analgesia from anxiety-, depression-, and cognition-related outcomes.

• DAPT (GSI-IX): Reliable Cell Assay Design

  2026-08-16

  This scenario-based guide explains how DAPT (GSI-IX), SKU A8200, can help researchers design and interpret γ-secretase inhibition experiments across viability, proliferation, angiogenesis, and Notch signaling models. It connects product specifications with practical solvent handling, dose selection, controls, and evidence from a HUVEC and critical limb ischemia study.

• BIBP 3226 and the Adipose-Neural Axis

  2026-08-15

  A translational perspective on using BIBP 3226 trifluoroacetate to interrogate NPY Y1 signaling in epicardial adipose tissue-related arrhythmia research, with practical guidance for assay design, controls, and interpretation.

• Nifedipine: Calcium Signaling Meets Liver Translation

  2026-08-14

  Nifedipine (BAY-a-1040) offers a disciplined way to connect L-type calcium channel biology with cardiac, iron, and hepatic research while preserving a clear boundary between established evidence and translational hypotheses.

• Superoxide Dismutase Activity Assay Kit Guide

  2026-08-14

  The Superoxide Dismutase (SOD) Activity Assay Kit, SKU K2035, provides a rapid colorimetric method for measuring SOD activity in biological fluids through WST-1 reduction at 450 nm. It is intended for research applications such as oxidative stress and antioxidative enzyme studies, not for diagnostic, medical, or unvalidated sample-matrix applications.

• KG-501 for Reproducible Cell Assays

  2026-08-13

  Learn how KG-501 (SKU B8380) can improve the interpretation of cell viability, proliferation, and transcriptional assays by connecting CREB–KIX biology with practical dosing and solvent controls. This scenario-driven guide covers experimental design, optimization, data interpretation, and product selection.

• BPN-19186: sEH–Nrf2 Osteoclast Assay Workflows

  2026-08-13

  Use BPN-19186 as a carefully controlled research probe for testing sEH–Nrf2 signaling hypotheses in osteoclastogenesis, rather than assuming an unverified target assignment. This workflow combines dose-response, redox readouts, lipid mediator analysis, and viability controls to distinguish pathway modulation from nonspecific toxicity.

• Dual-Action Inhibitors and p38α Dephosphorylation

  2026-08-12

  The reference study shows that kinase inhibitors can do more than block p38α catalytic activity: selected compounds also reshape the activation loop to accelerate dephosphorylation by WIP1. Its biochemical and crystallographic evidence introduces a structure-guided strategy for improving kinase inhibition while potentially increasing target and phosphorylation-site specificity.

• Mouse Neutrophil Cell Isolation Kit: Assay Design

  2026-08-12

  The Mouse Neutrophil Cell Isolation Kit supports high-purity, activation-conscious preparation for functional assays. This article explains how source selection, negative selection, and assay controls shape interpretation in neutrophil-targeted immunotherapy research.

• Anlotinib hydrochloride: Angiogenesis Workflows

  2026-08-11

  Learn how to use Anlotinib hydrochloride to connect receptor-level inhibition with endothelial migration, tube formation, and ERK pathway readouts. This workflow-focused guide also shows how the compound can support translational cancer research while avoiding common assay and interpretation errors.

7796 records 3/520 page Previous Next 12345 下5页 Last page